Infect Chemother.  2011 Oct;43(5):412-415. 10.3947/ic.2011.43.5.412.

A Case of Clostridium bifermentans Bacteremia in a Patient with Myelodysplastic Syndrome

• Lee JA
• Yoon HJ
• Kim JM
• Jo SM
• Choi YH
• Moon HJ
• Yun KH
• Kim HK
• Yang SE

• KMID: 2285014
• DOI: http://doi.org/10.3947/ic.2011.43.5.412

Abstract

Cases of anaerobic bacteremia are rare, and the clinical impact of clostridial bacteremia remains to be clarified. Previous clinical reports have suggested that C. bifermentans is less virulent than other Clostridia species. This microorganism has occasionally been reported to cause septic arthritis, necrotizing pneumonia with empyema, brain abscesses, endocarditis, and metastatic osteomyelitis. Herein, we report on a case of C. bifermentans bacteremia in a patient with myelodysplastic syndrome in South Korea.

Keyword

Clostridium bifermentans; Bacteremia; Myelodysplastic syndrome

MeSH Terms

Arthritis, Infectious
Bacteremia
Brain Abscess
Clostridium
Clostridium bifermentans
Empyema
Endocarditis
Humans
Myelodysplastic Syndromes
Osteomyelitis
Pneumonia
Republic of Korea

Reference

1. Pietrafitta JJ, Deckers PJ. Significance of clostridial bacteremia. Am J Surg. 1982. 143:519–522.

2. Chen YM, Lee HC, Chang CM, Chuang YC, Ko WC. Clostridium bacteremia: emphasis on the poor prognosis in cirrhotic patients. J Microbiol Immunol Infect. 2001. 34:113–118.

3. Kornbluth AA, Danzig JB, Bernstein LH. Clostridium septicum infection and associated malignancy: report of 2 cases and review of the literature. Medicine (Baltimore). 1989. 68:30–37.

4. Brook I. Yu VL, Merigan TC, Barriere SL, editors. Clostridium species. Antimicrobial Therapy and Vaccines. 1999. 1st ed. Maryland: Williams & Wilkins;146–148.

5. Scanlan DR, Smith MA, Isenberg HD, Engrassia S, Hilton E. Clostridium bifermentans bacteremia with metastatic osteomyelitis. J Clin Microbiol. 1994. 32:2867–2868.

6. Gorbach SL, Thadepalli H. lsolation of Clostridium in human infections: evaluation of 114 cases. J Infect Dis. 1975. 131:Suppl. S81–S85.

7. Kolander SA, Cosgrove EM, Molavi A. Clostridial endocarditis: report of a case caused by Clostnidium bifermentans and review of the literature. Arch Intern Med. 1989. 149:455–456.

8. Brook I. Recovery of anaerobic bacteria from wounds after lawn-mower injuries. Pediatr Emerg Care. 2005. 21:109–110.

9. Nachman S, Kaul A, Li KI, Slim MS, San Filippo JA, Van Horn K. Liver abscess caused by Clostridium bifermentans following blunt abdominal trauma. J Clin Microbiol. 1989. 27:1137–1138.

10. Bodey GP, Rodriguez S, Fainstein V, Elting LS. Clostridial bacteremia in cancer patients: a 12-year experience. Cancer. 1991. 67:1928–1942.

11. Park Y, Lee Y, Kim M, Choi JY, Yong D, Jeong SH, Kim JM, Lee K, Chong Y. Recent trends of anaerobic bacteria isolated from clinical specimens and clinical characteristics of anaerobic bacteremia. Infect Chemother. 2009. 41:216–223.

12. Rechner PM, Agger WA, Mruz K, Cogbill TH. Clinical features of clostridial bacteremia: a review from a rural area. Clin Infect Dis. 2001. 33:349–353.

13. Pomeroy C, Oken MM, Rydell RE, Filice GA. Infection in the myelodysplastic syndromes. Am J Med. 1991. 90:338–344.

14. Ednie LM, Credito KL, Khantipong M, Jacobs MR, Appelbaum PC. Synergic activity, for anaerobes, of trovafloxacin with clindamycin or metronidazole: chequerboard and time-kill methods. J Antimicrob Chemother. 2000. 45:633–638.

15. Wilson JR, Limaye AP. Risk factors for mortality in patients with anaerobic bacteremia. Eur J Clin Microbiol Infect Dis. 2004. 23:310–316.

16. Lassmann B, Gustafson DR, Wood CM, Rosenblatt JE. Reemergence of anaerobic bacteremia. Clin Infect Dis. 2007. 44:895–900.